EMBECTA CORP. Payments for Restructuring
EMBECTA CORP. (EMBC) reported Payments for Restructuring of $22.40 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2025-11-25
- EMBECTA CORP. payments for restructuring for the quarter ending 2025-09-30 was $900.00K.
- EMBECTA CORP. payments for restructuring for the quarter ending 2025-06-30 was $4.80M.
- EMBECTA CORP. payments for restructuring for the quarter ending 2025-03-31 was $15.20M.
- EMBECTA CORP. payments for restructuring for the quarter ending 2024-12-31 was $1.50M.
- EMBECTA CORP. payments for restructuring for fiscal 2025 was $22.40M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2025-09-30 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $5.70M derived: sum of 2 quarters · filed 2025-11-25 | $20.90M derived: sum of 3 quarters · filed 2025-11-25 | $22.40M 10-K · filed 2025-11-25 |
| 2025-06-30 | $4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $20.00M derived: sum of 2 quarters · filed 2025-08-08 | $21.50M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $15.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-09 | $16.70M 10-Q · filed 2025-05-09 | ||
| 2024-12-31 | $1.50M 10-Q · filed 2025-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |